Authors: Baudy, RB Fletcher, H Yardley, JP Zaleska, MM Bramlett, DR Tasse, RP Kowal, DM Katz, AH Moyer, JA Abou-Gharbia, M

Citation: Rb. Baudy et al., Design, synthesis, SAR, and biological evaluation of highly potent benzimidazole-spaced phosphono-alpha-amino acid competitive NMDA antagonists of the AP-6 type, J MED CHEM, 44(10), 2001, pp. 1516-1529

Authors: Bartolomeo, AC Morris, H Buccafusco, JJ Kille, N Rosenzweig-Lipson, S Husbands, MG Sabb, AL Abou-Gharbia, M Moyer, JA Boast, CA

Citation: Ac. Bartolomeo et al., The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist, J PHARM EXP, 292(2), 2000, pp. 584-596

Authors: Boast, C Bartolomeo, AC Morris, H Moyer, JA

Citation: C. Boast et al., 5HT antagonists attenuate MK801-impaired radial arm maze performance in rats, NEUROBIOL L, 71(3), 1999, pp. 259-271

Authors: Sabb, AL Husbands, GM Tokolics, J Stein, RP Tasse, RP Boast, CA Moyer, JA Abou-Gharbia, M

Citation: Al. Sabb et al., Discovery of a highly potent, functionally-selective muscarinic M-1 agonist,WAY-132983 using rational drug design and receptor modelling, BIOORG MED, 9(14), 1999, pp. 1895-1900

Authors: Abou-Gharbia, MA Childers, WE Fletcher, H McGaughey, G Patel, U Webb, MB Yardley, J Andree, T Boast, C Kucharik, RJ Marquis, K Morris, H Scerni, R Moyer, JA

Citation: Ma. Abou-gharbia et al., Synthesis and SAR of adatanserin: Novel adamantyl aryl- and heteroarylpiperazines with dual serotonin 5-HT1A and 5-HT2 activity as potential anxiolytic and antidepressant agents, J MED CHEM, 42(25), 1999, pp. 5077-5094